Your Health and Fitness Partner: Androxal & FitHub

We are also excited to expand our scope by including valuable information on Androxal, a potent medication beneficial in various medical conditions. This remarkable drug, derived from the testosterone molecule, has made its mark significantly in the field of endocrinology. Patients and medical professionals can rely on our comprehensive, unbiased, and scientifically grounded content on Androxal for gaining a robust understanding of its uses, side effects, and the latest studies related to it. We understand the necessity of accurate information when it comes to medication. Our newly launched section dedicated to Androxal aims at not only educating the readers about its nuances but also at contributing beneficially to their wellbeing. Stay tuned for insightful articles unraveling the potential of Androxal in medical science.

Sitemap | Policies | Feedback    
 About the Journal
Editorial Board
Journal Subscription
Instructions for Authors
E-mail Alerts
Forthcoming Events
Advertise with Us
Contact Us
 
Article Options
FULL TEXT
ABSTRACT
PDF
Printer Friendly Version
Search Pubmed for
Search Google Scholar for
Article Statistics
Bookmark and Share
 
The profile of inflammatory bowel disease in natives of Western Himalayas
 
Jai Bharat Sharma1, Brij Sharma2, Rajesh Sharma2, Sanjay K Mahajan1, Rajiv Raina1, Priyanka Sharma3
1Department of Medicine, 2Department of Gastroenterology, 3Department of OBG and Gynaecology. Indira Gandhi Medical College, Shimla, Himachal Pradesh.


Corresponding Author
:
Jai Bharat Sharma
Email: jai561989igmc@gmail.com


Abstract

Background: To study the profile of Inflammatory Bowel Disease (IBD) in natives of Himachal Pradesh.
Material and Methods: A total of 101 patients of IBD were included. The clinical profiles, disease activity, severity and response to therapy were evaluated. 
Results: Of the 101 patients, 82% were diagnosed with Ulcerative Colitis (UC), 12% with Crohn’s Disease (CD) and 6% with Inflammatory Bowel Disease Unclassified (IBDU). The mean duration between onset of symptoms and diagnosis was 12.3 months for UC, 15 months for CD and 3 months for IBDU. Chronic diarrhea (98%) and blood in stools (94%) were most common symptom in UC and abdominal pain (83%) was most common in CD. E2(45.78%) disease was most common in UC, L2(50%) was most common in CD and Left sided colonic involvement was most common in IBDU (83%). Extra intestinal manifestations were noted in IBDU (67%), CD (50%) and UC (40%). Most of the patients had moderate disease activity and responded well to pharmacotherapy.
Conclusion: IBD is not uncommon in the rural hilly areas of India. There is predominance of ulcerative colitis rather than Crohn’s disease.